Pulsenmore
Pulsenmore Ltd., a medical device company, engages in the research, development, manufacture, marketing, and sale of portable ultrasound solutions. Based in Omer.
Pulsenmore: sales sharply up (+52.0%), net income sharply down (−51.5%), cash flow down (−12.9%).
- Sales sharply upH1 2026
Revenue: ₪6M, vs. ₪4M a year earlier, i.e. +52.0%.
- Net income sharply downH1 2026
Net income: ₪−35M, vs. ₪−23M a year earlier, i.e. −51.5%.
- Cash flow downH1 2026
Operating cash flow: ₪−18M, vs. ₪−16M a year earlier, i.e. −12.9%.
- Operating income stableH1 2026
Operating income: ₪−21M, vs. ₪−21M a year earlier, i.e. −0.7%.
What the market pays, vs. the sector
This company's valuation multiples history is being built day by day from now on.
P/E calculated on net income (trailing 12 months: last fiscal year + H1 2026 − same period a year earlier). Sector median: companies in the group tracked here. Prices: Yahoo Finance; market cap cross-checked with the Tel Aviv Stock Exchange for Israeli stocks. These ratios describe a price, not a value: none of them says whether the share is expensive or cheap.
Trades by executives and interested parties
2 filing(s) over 12 months · on shares: 1 increase(s) and 1 decrease(s) in holdings.
| Date | Holder | Security | Direction | Quantity | Price | |
|---|---|---|---|---|---|---|
| 03/11/2025 | General Electric Company Interested party | Shares | Down | 3,593,429 | ₪4.66 | Maya › |
| 09/12/2025 | Lazar Sonnenschein Director | Shares | Up | 10,012 | ₪2.50 | Maya › |
Filings submitted on Maya (executives, directors, shareholders above 5%). An increase or decrease in holdings may come from a purchase or sale on the exchange, but also from a grant or exercise of options (price "—": grant with no price). Bonds excluded. For details, see the filing on Maya.
Follow earnings · WhatsApp group TA-125Details ▾
Every report from a TA-125 company, analyzed the same day: key figures and year-on-year change, analysis in brief, share price reaction. One daily summary during earnings season.
Join the TA-125 groupDetailed figures and history
Financial summary
| S1 2026 | S1 2025 | FY 2025 | |
|---|---|---|---|
| Total assets | 100 | 120 | 102 |
| Current assets | 80 | 112 | 81 |
| Non-current assets | 20 | 8 | 20 |
| Equity | 48 | 75 | 83 |
| of which minority interests | 0 | 0 | 0 |
| Current liabilities | 44 | 14 | 10 |
| Non-current liabilities | 8 | 32 | 8 |
| Revenue | 6 | 4 | 40 |
| Gross profit | 2 | 1 | 34 |
| Operating income | −21 | −21 | −12 |
| Pre-tax income | −35 | −23 | −16 |
| Net income | −35 | −23 | −16 |
| Net income (attributable to shareholders) | −35 | −23 | −16 |
| Dividends paid | 0 | 0 | 0 |
| Operating cash flow | −18 | −16 | −33 |
In millions of shekels. The "H1" columns cover the first six months of the year.
Calculated from these figures
| S1 2026 | S1 2025 | FY 2025 | |
|---|---|---|---|
| Gross margin | 36.6% | 36.4% | 84.2% |
| Operating margin | −341.4% | −515.7% | −30.4% |
| Net margin | −576.8% | −579.1% | −39.6% |
| Current ratio (current assets / current liabilities) | 1,8 x | 8,0 x | 7,9 x |
| Equity / total assets | 48.4% | 61.9% | 81.6% |
The 5-year history, charts and cross-check models are coming for companies listed only in Tel Aviv: each new filing on Maya is kept and enriches the page.
Company overview
Pulsenmore Ltd., a medical device company, engages in the research, development, manufacture, marketing, and sale of portable ultrasound solutions. The company provides Pulsenmore ES and Pulsenmore FC products in the United States, the United Kingdom, Northern Ireland, and Europe. The company was incorporated in 2014 and is based in Omer, Israel.
Source: official company profile (Yahoo Finance), summary. Website: www.pulsenmore.com
- Maya, Tel Aviv Stock Exchange: company page and reports
No dividend paid over the past five years (source: Yahoo Finance).